https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/Ironwood-Pharmaceuticals-Announces-Agreement-with-Teva-Involving-LINZESS-linaclotide-72-mcg-Dosage-Strength/default.aspx
https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/Ironwood-Pharmaceuticals-Announces-Agreement-with-Teva-Involving-LINZESS-linaclotide-72-mcg-Dosage-Strength/default.aspx